PremiumThe FlyGalera Therapeutics reports Q2 EPS (7c) vs. (48c) last year Galera Therapeutics to reduce workforce to three employees Galera Therapeutics announces board approval of liquidation, dissolution PremiumThe FlyGalera Therapeutics reports Q1 EPS (8c) vs (50c) last year Galera Therapeutics Enacts Plan to Deter Hostile Takeovers Galera Therapeutics adopts limited duration stockholder rights agreement PremiumPre-EarningsGRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings? Biotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today